Ovid Therapeutics Inc.
OVID | NASDAQ
$2.71
+$0.02 (+0.74%)
At close: Sep 21, 2026, 4:00 PM ET
$2.75
+$0.04 (+1.48%)
Pre-market:
Sep 22, 2026, 8:47 AM ET
Institutional Ownership
Net InflowTotal Institutions
109
Total Ownership
142.49%
Capital Flow
+$132.49M
Shares Change
+43.19M
Ownership Distribution
Institutions (99.99%)
Others (0.01%)
Institutional Sentiment
Overall: neutralEquity Sentiment & Activity
bullishNew Positions
29
Increased Positions
62
Reduced Positions
20
Closed Positions
11
New (29)
Increased (62)
Reduced (20)
Closed (11)
Options Sentiment & Activity
bearishPut/Call Ratio
1.626
Call Flow
110,600
Put Flow
179,800
Calls (38%)
Puts (62%)
Super Investors
| Super Investor / Fund | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| Point72 Asset Management LP | 1.79% -62.81% | < 0.01% | 1.32M | 3.7M |
Top Shareholders
| Institution | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| Ra Capital Management, L.p. | 14.53% +10.76% | 0.25% +40.86% | 10.71M 0.00% | 23.79M +36.20% | |
| Janus Henderson Group PLC | 14.53% +100.00% | 0.01% +100.00% | 10.71M +100.00% | 23.73M +100.00% | |
| Affinity Asset Advisors, LLC | 14.42% +64.77% | 1.22% +83.63% | 10.64M +48.76% | 23.61M +102.61% |
Pro Membership
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
Unlimited access
Unlimited access to all data and tools, giving you the edge over everyone else in the market.
Proprietary Stock Rating Score
Evaluate stocks with our proprietary rating score based on fundamentals, economic moat, and sentiment.
Top Wall Street Analyst Ratings
Follow ratings from the best analysts on Wall Street to stay ahead of market moves.
Up to 30 years financial history
We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Add to Watchlist
Select watchlists to add or remove OVID